Clinical Trial Update: Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated sublingual tacrolimus in adult patients undergoing blood and marrow stem cell transplantation; the study is completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Transplant
• Immunosuppression
• Stem Cell Transplant

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Mayo Clinic | Conditions: Immunosuppression, Stem Cell Transplant | Phase 4 | Status: COMPLETED | Results posted: 2020-08-07